Mathai Rashmi Teresa K, Bhat Smitha
Senior Resident, Department of General Medicine, Father Muller Medical College , Mangalore - 575002, Karnataka, India .
J Clin Diagn Res. 2013 Jun;7(6):1109-13. doi: 10.7860/JCDR/2013/5977.3094. Epub 2013 Apr 29.
COPD is a major global health problem affecting 4-10% of Indian adult male population. Immunological processes have been implicated in the pathogenesis of COPD. As compared to healthy smokers, COPD patients have airway inflammation indicated by the presence of CD8+ T cells in the lung. This predominant increase in CD8+ T cells in the lung may be reflected in the peripheral blood. In an attempt to understand why only some smokers develop COPD, we compared the peripheral T-cell markers in COPD patients with that of asymptomatic smokers, and healthy nonsmokers.
Twenty healthy non-smokers (HNS), 19 asymptomatic smokers (AS) and 21 COPD male patients (age and pack year-matched) were identified after clinical evaluation and spirometry. Blood CD3+, CD4+, CD8+ T-cell populations were measured.
Smokers with COPD had severe airflow limitation (FVC, 69.8+16.7%; FEV1, 47.47+16.9%; FEV1/FVC, 53.1+13.3%). The BMI was found to be significantly lower among patients with COPD (19.1+4.8kg/m(2)) as compared to AS (23+4.3kg/m(2)) and HNS (23.7+4.0kg/m(2)) (p value = 0.003 HS). The mean CD3+T-cell absolute count in COPD patients (1154.3+582.2), showed a marked decline as compared to that of AS (1251.9+491.6) and HNS (1424.9+352.2). The mean CD4+T-cell counts in COPD patients (652.7+340.5) were also lower when compared to AS (745.7+313.8) and HNS (832.5+220.7). The mean CD8+T-cell counts among COPD patients (424.7+264.3) were, similar to the counts observed among AS (426.9+193.2) and HNS (500.4+191). Though not statistically significant, the absolute counts of CD3+, CD4+ and CD8+ lymphocytes among COPD patients tended to be lower. No significant difference in the CD4+/CD8+ lymphocyte ratio between the patient groups was observed.
Our study indicates that BMI is related to the severity of COPD, hence proving a systemic component to its pathogenesis. However, we found similar percentages of CD8+Tcells in all the study groups suggesting that predominant CD8+ T cells in the airways may be due to its de novo origin rather than recruitment from blood. However, larger studies are needed to clarify the effect of disease severity, beedi smoking and ethnicity.
慢性阻塞性肺疾病(COPD)是一个重大的全球健康问题,影响着4%至10%的印度成年男性人口。免疫过程与COPD的发病机制有关。与健康吸烟者相比,COPD患者肺部存在CD8 + T细胞,提示有气道炎症。肺部CD8 + T细胞的这种显著增加可能在外周血中有所体现。为了试图理解为什么只有部分吸烟者会患上COPD,我们比较了COPD患者与无症状吸烟者以及健康非吸烟者的外周血T细胞标志物。
经过临床评估和肺功能测定,确定了20名健康非吸烟者(HNS)、19名无症状吸烟者(AS)和21名COPD男性患者(年龄和吸烟包年数匹配)。检测血液中CD3 +、CD4 +、CD8 + T细胞群体。
患有COPD的吸烟者存在严重的气流受限(用力肺活量[FVC],69.8 + 16.7%;第1秒用力呼气容积[FEV1],47.47 + 16.9%;FEV1/FVC,53.1 + 13.3%)。与无症状吸烟者(23 + 4.3kg/m²)和健康非吸烟者(23.7 + 4.0kg/m²)相比,COPD患者的体重指数(BMI)显著更低(19.1 + 4.8kg/m²)(p值 = 0.003,与健康非吸烟者相比)。COPD患者的平均CD3 + T细胞绝对计数(1154.3 + 582.2)与无症状吸烟者(1251.9 + 491.6)和健康非吸烟者(1424.9 + 352.2)相比显著下降。与无症状吸烟者(745.7 + 313.8)和健康非吸烟者(832.5 + 220.7)相比,COPD患者的平均CD4 + T细胞计数(652.7 + 340.5)也更低。COPD患者的平均CD8 + T细胞计数(424.7 + 264.3)与无症状吸烟者(426.9 + 193.2)和健康非吸烟者(500.4 + 191)中观察到的计数相似。虽然无统计学意义,但COPD患者中CD3 +、CD4 +和CD8 +淋巴细胞的绝对计数往往更低。各患者组之间的CD4 + /CD8 +淋巴细胞比值无显著差异。
我们的研究表明BMI与COPD的严重程度相关,因此证明其发病机制中有一个系统性因素。然而,我们发现所有研究组中CD8 + T细胞的百分比相似,提示气道中占主导的CD8 + T细胞可能是由于其新生来源而非从血液中募集。然而,需要更大规模的研究来阐明疾病严重程度、吸比迪烟和种族的影响。